4.7 Article

Aetiology of, and risk factors for, recurrent community-acquired pneumonia

期刊

CLINICAL MICROBIOLOGY AND INFECTION
卷 15, 期 11, 页码 1033-1038

出版社

ELSEVIER SCI LTD
DOI: 10.1111/j.1469-0691.2009.02918.x

关键词

Chronic obstructive pulmonary disease; community-acquired pneumonia; pneumococcal pneumonia; pneumococcal vaccination; recurrence

资金

  1. Ministerio de Sanidad y Consumo [REIPI RD06/0008]
  2. Institute de Salud Carlos III
  3. Spanish Network for the Research in Infectious Diseases
  4. Fondo de Investigacio n Sanitaria de la Seguridad Social [04/0139]
  5. Institut d'Investigacio Biomedica de Bellvitge (Garcia-Vidal)

向作者/读者索取更多资源

P>Recurrent community-acquired pneumonia (CAP) requiring hospitalization is a matter of particular concern. However, current information on its prevalence, aetiology and risk factors is lacking. To address these issues, we performed an observational analysis of a prospective cohort of hospitalized adults with CAP. Recurrence was defined as two or more episodes of CAP 1 month apart within 3 years. Patients with severe immunosuppression or local predisposing factors were excluded. Of the 1556 patients, 146 (9.4%) had recurrent CAP. The most frequent causative organism was Streptococcus pneumoniae, both in patients with recurrent CAP and in those without recurrence. Haemophilus influenzae, other Gram-negative bacilli and aspiration pneumonia were more frequent among patients with recurrent CAP, whereas Legionella pneumophila was rarely identified in this group. Independent factors associated with recurrent CAP were greater age, lack of pneumococcal vaccination, chronic obstructive pulmonary disease (COPD) and corticosteroid therapy. In a sub-analysis of 389 episodes of pneumococcal pneumonia, the only independent risk factor for recurrence was lack of pneumococcal vaccination. Recurrence of CAP is not a rare clinical problem and it occurs mainly in the elderly, patients with COPD, and those receiving corticosteroids. Our study provides support for recommending pneumococcal vaccination for adults at risk of pneumonia, including those with a first episode of CAP.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Public, Environmental & Occupational Health

Impact of the coronavirus disease 2019 (COVID-19) pandemic on infection control practices in a university hospital

Gabriela Abelenda-Alonso, Mireia Puig-Asensio, Emilio Jimenez-Martinez, Esther Garcia-Lerma, Ana Hornero, Carmen Gutierrez, Miriam Torrecillas, Cristian Tebe, Miquel Pujol, Jordi Carratala

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Immunology

Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

Mario Fernandez-Ruiz, Marta Bodro, Isabel Gutierrez Martin, Regino Rodriguez-Alvarez, Maria Ruiz-Ruigomez, Nuria Sabe, Teresa Lopez-Vinau, Maricela Valerio, Aitziber Illaro, Jesus Fortun, Sonsoles Salto-Alejandre, Elisa Cordero, Maria del Carmen Farinas, Patricia Munoz, Elisa Vidal, Jordi Carratala, Josune Goikoetxea, Antonio Ramos-Martinez, Asuncion Moreno, Jose Maria Aguado

Summary: Retrospective study shows that isavuconazole is a safe and effective treatment option for invasive mold disease in solid organ transplantation recipients. Clinical response was achieved in over 50% of patients by weeks 6 and 12, and adverse events were relatively low.

TRANSPLANTATION (2023)

Article Microbiology

Increasing Gram-Negative Catheter-Related Bloodstream Infection in Cancer Patients

Julia Laporte-Amargos, Enric Sastre, Alba Bergas, Helena Pomares, Annalisa Paviglianiti, Marisol Rodriguez-Arias, Natalia Pallares, Ana Maria Badia-Tejero, Paula Pons-Oltra, Jordi Carratala, Carlota Gudiol

Summary: This study aimed to assess the incidence, etiology, and outcomes of catheter-related bloodstream infection (CRBSI) in onco-hematological patients. The results showed that Gram-positive bacteria were the main pathogens causing infection, while the incidence of Gram-negative bacteria increased over time. Multidrug-resistant Gram-negative bacteria were also on the rise. It was also found that the non-removal of the catheter was associated with decreased survival rates.

PATHOGENS (2023)

Article Biochemistry & Molecular Biology

Whole-Blood Gene Expression Profiles Associated with Mortality in Community-Acquired Pneumonia

Diego Viasus, Antonella E. F. Simonetti, Lara Nonell, Oscar Vidal, Yolanda Meije, Lucia Ortega, Magdalena Arnal, Marta Bodalo-Torruella, Montserrat Sierra, Alexander Rombauts, Gabriela Abelenda-Alonso, Gemma Blanchart, Carlota Gudiol, Jordi Carratala

Summary: We examined the differences in gene expression profiles in patients with community-acquired pneumonia (CAP) who died during hospitalization and those who survived. Whole blood samples were obtained for genome-expression-profile analysis within 24 hours of admission. The study found significant differences in gene expression at hospital admission between patients who died and those who survived. These findings could help identify potential intervention targets and biomarkers for risk stratification.

BIOMEDICINES (2023)

Article Surgery

Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

Elena Perez-Nadales, Mario Fernandez-Ruiz, Alejandra M. Natera, Belen Gutierrez-Gutierrez, Alessandra Mularoni, Giovanna Russelli, Ligia Camera Pierrotti, Maristela Pinheiro Freire, Marco Falcone, Giusy Tiseo, Mario Tumbarello, Francesca Raffaelli, Edson Abdala, Marta Bodro, Elena Gervasi, Maria Carmen Farinas, Elena M. Seminari, Juan Jose Caston, Juan Antonio Marin-Sanz, Victor Galvez-Soto, Meenakshi M. Rana, Belen Loeches, Pilar Martin-Davila, Alvaro Pascual, Jesus Rodriguez-Bano, Jose Maria Aguado, Luis Martinez-Martinez, Julian Torre-Cisneros, REIPI INCREMENT-SOT Study Grp

Summary: This study compared the efficacy of ceftazidime-avibactam (CAZ-AVI) and the best available therapy (BAT) in treating solid organ transplant recipients with bloodstream infection caused by carbapenemase-producing Klebsiella pneumoniae. The results showed that patients treated with CAZ-AVI had higher clinical success rates at 14-day and 30-day and lower 30-day mortality compared to those receiving BAT.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Article Pediatrics

Executive summary - Diagnosis, treatment and prophylaxis of influenza virus infection - Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

Francisco Lopez-Medrano, Santiago Alfayate, Jordi Carratala, Judith Chamorro-Camazon, Elisa Cordero, Marta Cruz-Canete, Maria Fernandez-Pradai, Manuel Garcia-Cenoz, Maria Angeles Marcos, Santiago Melon, Nemesio Moreno-Millan, Maria Angeles Onieva-Garcian, Raul Ortiz de Lejarazuo, Jaime Jesus Perez-Martin, Juan Rodriguez-Garcia, German Schwarz-Chavarrir, Alfredo Tagarro-Garcia, Diego van Esso-Arbolave, Diego Viasus, Tomas Pumarola

Summary: This consensus document is the result of collaboration among various Spanish scientific societies, aiming to reduce the important consequences of influenza virus infection by facilitating the approach to clinical, microbiological, and preventive aspects of the disease.

ANALES DE PEDIATRIA (2023)

Article Primary Health Care

Executive summary-- Diagnosis, treatment and prophylaxis of influenza virus infection-- Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

Francisco Lopez-Medrano, Santiago Alfayate, Jordi Carratala, Judith Chamorro-Camazon, Elisa Cordero, Marta Cruz-Canete, Maria Fernandez-Prada, Manuel Garcia-Cenoz, M. Angeles Marcos, Santiago Melon, Nemesio Moreno-Millan, Maria Angeles Onieva-Garcia, Raul Ortiz de Lejarazu, Jaime Jesus Perez-Martin, Juan Rodriguez-Garcia, German Schwarz-Chavarri, Alfredo Tagarro-Garcia, Diego van Esso-Arbolave, Diego Viasus, Tomas Pumarola

Summary: This article is a collaboration of various Spanish scientific societies and covers the clinical, microbiological, therapeutic, and preventive aspects of influenza virus infection. It aims to reduce the significant impact of influenza virus infection on the population's health.

ATENCION PRIMARIA (2023)

Article Infectious Diseases

Changing Trends in the Global Consumption of Treatments Used in Hospitalized Patients for COVID-19: A Time Series Multicentre Study

Judit Aranda, Jose Loureiro-Amigo, Anna Murgadella, Nuria Vazquez, Lucia Feria, Miriam Munoz, Ariadna Padulles, Gabriela Abelenda, Carol Garcia-Vidal, Montse Tuset, Marta Albanell, Lucia Boix-Palop, Nuria Sanmarti-Martinez, Silvia Gomez-Zorrilla, Daniel Echeverria-Esnal, Alicia Rodriguez-Alarcon, Beatriz Borjabad, Ana Coloma, Jordi Carratala, Isabel Oriol

Summary: This study analyzed the prescription trends of COVID-19 treatments for hospitalized patients in Barcelona. The use of lopinavir/ritonavir and hydroxychloroquine declined over time and was replaced by remdesivir. Tocilizumab use showed a varying trend, while dexamethasone use increased. Antibiotic use, particularly azithromycin, decreased after the initial months of the pandemic. The findings highlight the importance of adapting treatment strategies based on evolving scientific evidence.

ANTIBIOTICS-BASEL (2023)

Article Infectious Diseases

Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients

Javier Martinez-Casanova, Erika Esteve-Pitarch, Helena Colom-Codina, Victor Daniel Gumucio-Sanguino, Sara Cobo-Sacristan, Evelyn Shaw, Kristel Maisterra-Santos, Joan Sabater-Riera, Xose L. Perez-Fernandez, Raul Rigo-Bonnin, Fe Tubau-Quintano, Jordi Carratala, Ariadna Padulles-Zamora

Summary: This study aimed to characterize the pharmacokinetics of piperacillin after continuous infusion administration in critically ill adult patients and determine the optimal dosing regimen. The population pharmacokinetic approach was used to analyze piperacillin concentrations from 106 patients. Creatinine clearance was found to be the most predictive factor of piperacillin clearance. The model developed can be used for initial dose guidance and therapeutic drug monitoring.

ANTIBIOTICS-BASEL (2023)

Article Biochemistry & Molecular Biology

Dynamics of Gene Expression Profiling and Identification of High-Risk Patients for Severe COVID-19

Alexander Rombauts, Marta Bodalo Torruella, Gabriela Abelenda-Alonso, Julia Perera-Bel, Anna Ferrer-Salvador, Ariadna Acedo-Terrades, Maria Gabarros-Subira, Isabel Oriol, Carlota Gudiol, Lara Nonell, Jordi Carratala

Summary: The clinical manifestations of SARS-CoV-2 infection vary widely, from asymptomatic infection to severe respiratory complications. The host response to the virus plays a crucial role in determining the outcomes. This study aimed to understand the differences in gene expression and immune response in COVID-19 patients with and without acute respiratory distress syndrome (ARDS). Blood samples were collected from 60 hospitalized patients with confirmed SARS-CoV-2 infection, and significant differences in gene expression were found between the ARDS and non-ARDS groups, including dysregulated inflammatory response and altered immune regulation.

BIOMEDICINES (2023)

Article Virology

Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients

Jose Luis Pinana, Inmaculada Heras, Tommaso Francesco Aiello, Irene Garcia-Cadenas, Lourdes Vazquez, Javier Lopez-Jimenez, Pedro Chorao, Cristina Aroca, Carolina Garcia-Vidal, Ignacio Arroyo, Eva Soler-Espejo, Lucia Lopez-Corral, Alejandro Avendano-Pita, Anna Arrufat, Valentin Garcia-Gutierrez, Elena Arellano, Lorena Hernandez-Medina, Clara Gonzalez-Santillana, Julia Morell, Jose angel Hernandez-Rivas, Paula Rodriguez-Galvez, Mireia Mico-Cerda, Manuel Guerreiro, Diana Campos, David Navarro, Angel Cedillo, Rodrigo Martino, Carlos Solano

Summary: This study analyzed the outcomes of hematological patients with SARS-CoV-2 infection who received treatment with remdesivir or nirmatrelvir/ritonavir. The results showed that nirmatrelvir/ritonavir was safe and effective for treating mild cases, while remdesivir was preferred for moderate to severe cases with a higher mortality rate. Factors such as male gender, corticosteroid use, and co-infection were associated with worse outcomes in patients treated with remdesivir.

VIRUSES-BASEL (2023)

Review Medicine, General & Internal

Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review

Francisco Javier Candel, Miguel Salavert, Angel Estella, Miquel Ferrer, Ricard Ferrer, Julio Javier Gamazo, Carolina Garcia-Vidal, Juan Gonzalez del Castillo, Victor Jose Gonzalez-Ramallo, Federico Gordo, Manuel Miron-Rubio, Javier Perez-Pallares, Cristina Pitart, Jose Luis del Pozo, Paula Ramirez, Pedro Rascado, Soledad Reyes, Patricia Ruiz-Garbajosa, Borja Suberviola, Pablo Vidal, Rafael Zaragoza

Summary: Nosocomial pneumonia and ventilator-associated pneumonia are significant global health problems, causing high morbidity and mortality rates. This scientific manuscript reviews important aspects of the management of these infectious respiratory syndromes, providing updates on etiological perspectives, diagnostic techniques, treatment options, and preventive strategies.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Infectious Diseases

Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study

Mar Ronda, Josep Manuel Llop-Talaveron, MariPaz Fuset, Elisabet Leiva, Evelyn Shaw, Victor Daniel Gumucio-Sanguino, Yolanda Diez, Helena Colom, Raul Rigo-Bonnin, Mireia Puig-Asensio, Jordi Carratala, Ariadna Padulles

Summary: This study compared the pharmacokinetics of voriconazole in critically ill patients with and without extracorporeal membrane oxygenation (ECMO) support. The results showed that the ECMO group had lower minimum plasma concentration (C-min) and a higher prevalence of subtherapeutic C-min values. ECMO support and plasma albumin levels were identified as risk factors for low C-min values. Drug optimization is crucial for achieving therapeutic C-min levels in the ECMO group.

ANTIBIOTICS-BASEL (2023)

Review Biochemistry & Molecular Biology

A Systematic Review of Gene Expression Studies in Critically Ill Patients with Sepsis and Community-Acquired Pneumonia

Diego Viasus, Lara Nonell, Carlos Restrepo, Fabian Figueroa, Carla Donado-Mazarron, Jordi Carratala

Summary: This study summarizes the reported differentially expressed genes (DEGs) in critically ill septic patients with community-acquired pneumonia (CAP) and investigates their functional implications. The results highlight the complexity of immune responses during CAP.

BIOMEDICINES (2023)

Article Immunology

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

Tomas O. Jensen, Greg A. Grandits, Mamta K. Jain, Thomas A. Murray, Birgit Grund, Kathryn Shaw-Saliba, Michael A. Matthay, Mahsa Abassi, Magdalena Ardelt, Jason V. Baker, Peter Chen, Robin L. Dewar, Anna L. Goodman, Timothy J. Hatlen, Helene C. Highbarger, Mark Holodniy, Perrine Lallemand, Sylvain Laverdure, Bradley G. Leshnower, David Looney, Charalampos D. Moschopoulos, Henry Mugerwa, Daniel D. Murray, Eleftherios Mylonakis, Stephanie Nagy-Agren, M. Tauseef Rehman, Adam Rupert, Randy A. Stevens, Stuart Turville, Amy Weintrob, Katherine Wick, Jens Lundgren, Emily R. Ko

Summary: This study suggests that neutralizing monoclonal antibodies have an antiviral effect among hospitalized patients with COVID-19, without affecting the endogenous anti-nucleocapsid antibody response, systemic inflammation, or clinical status on day 5.

JOURNAL OF INFECTIOUS DISEASES (2023)

暂无数据